 | • レポートコード：QFJ1-5645 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、CARASIL治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（小胞モノアミン輸送体2阻害剤、選択的セロトニン再取り込み阻害剤（SSRI）、コリン作動性/コリンエステラーゼ（Che）阻害剤、非定型抗精神病薬、併用薬（ドネペジルとメマンチン）、MAO阻害剤、グルタミン酸阻害剤）、用途別市場規模（病院、診療所、ドラッグストア、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・CARASIL治療の市場動向 ・企業の競争状況、市場シェア ・CARASIL治療の種類別市場規模と予測2016-2027（小胞モノアミン輸送体2阻害剤、選択的セロトニン再取り込み阻害剤（SSRI）、コリン作動性/コリンエステラーゼ（Che）阻害剤、非定型抗精神病薬、併用薬（ドネペジルとメマンチン）、MAO阻害剤、グルタミン酸阻害剤） ・CARASIL治療の用途別市場規模と予測2016-2027（病院、診療所、ドラッグストア、オンライン薬局） ・CARASIL治療の北米市場規模2016-2027（アメリカ、カナダ） ・CARASIL治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・CARASIL治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・CARASIL治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・CARASIL治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（GlaxoSmithKline、Raptor Pharmaceutical、Pfizer、Vertex Pharmaceuticals Incorporated、Ceregene Inc.、AmpliPhi Biosciences Corporation、H. Lundbeck A/S、Omeros Ipsen、Novartis AG、Aurobindo Pharma、Prana Biotechnology、Alnylam Pharmaceuticals Inc.、SOM Biotech、Teva Pharmaceutical Industries Ltd.） ・結論 |
Carasil is distinguishing by injury to the small blood vessels within the brain as well as the destruction of myelin in the central nervous system. Carasil treatment is an immensely rare genetic disorder in which individuals with carasil are exposing to risk associating with numerous strokes as well as symptoms of dementia like difficulty in problem-solving, memory loss, etc. Furthermore, they do not encompass cardiovascular uncertainty factors. Whereas nearly all dementia complications regarding carasil are progressive and slow.
Market Analysis and Insights: Global Carasil Treatment Market
The global Carasil Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Carasil Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Carasil Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Carasil Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Carasil Treatment market.
Global Carasil Treatment Scope and Market Size
Carasil Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Carasil Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Vesicular Monoamine Transporter 2 Inhibitors
Selective Serotonin Reuptake Inhibitor (SSRI)
Cholinergic/ Cholinesterase (Che) Inhibitors
Atypical Antipsychotic Drugs
Combined Drug (Donepezil & Memantine)
MAO Inhibitors
Glutamate Inhibitors
Segment by Application
Hospital
Clinics
Drug Store
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
GlaxoSmithKline
Raptor Pharmaceutical
Pfizer
Vertex Pharmaceuticals Incorporated
Ceregene Inc.
AmpliPhi Biosciences Corporation
H. Lundbeck A/S
Omeros Ipsen
Novartis AG
Aurobindo Pharma
Prana Biotechnology
Alnylam Pharmaceuticals Inc.
SOM Biotech
Teva Pharmaceutical Industries Ltd.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Carasil Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Vesicular Monoamine Transporter 2 Inhibitors
1.2.3 Selective Serotonin Reuptake Inhibitor (SSRI)
1.2.4 Cholinergic/ Cholinesterase (Che) Inhibitors
1.2.5 Atypical Antipsychotic Drugs
1.2.6 Combined Drug (Donepezil & Memantine)
1.2.7 MAO Inhibitors
1.2.8 Glutamate Inhibitors
1.3 Market by Application
1.3.1 Global Carasil Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Drug Store
1.3.5 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Carasil Treatment Market Perspective (2016-2027)
2.2 Carasil Treatment Growth Trends by Regions
2.2.1 Carasil Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Carasil Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Carasil Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Carasil Treatment Industry Dynamic
2.3.1 Carasil Treatment Market Trends
2.3.2 Carasil Treatment Market Drivers
2.3.3 Carasil Treatment Market Challenges
2.3.4 Carasil Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Carasil Treatment Players by Revenue
3.1.1 Global Top Carasil Treatment Players by Revenue (2016-2021)
3.1.2 Global Carasil Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Carasil Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Carasil Treatment Revenue
3.4 Global Carasil Treatment Market Concentration Ratio
3.4.1 Global Carasil Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Carasil Treatment Revenue in 2020
3.5 Carasil Treatment Key Players Head office and Area Served
3.6 Key Players Carasil Treatment Product Solution and Service
3.7 Date of Enter into Carasil Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Carasil Treatment Breakdown Data by Type
4.1 Global Carasil Treatment Historic Market Size by Type (2016-2021)
4.2 Global Carasil Treatment Forecasted Market Size by Type (2022-2027)
5 Carasil Treatment Breakdown Data by Application
5.1 Global Carasil Treatment Historic Market Size by Application (2016-2021)
5.2 Global Carasil Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Carasil Treatment Market Size (2016-2027)
6.2 North America Carasil Treatment Market Size by Type
6.2.1 North America Carasil Treatment Market Size by Type (2016-2021)
6.2.2 North America Carasil Treatment Market Size by Type (2022-2027)
6.2.3 North America Carasil Treatment Market Size by Type (2016-2027)
6.3 North America Carasil Treatment Market Size by Application
6.3.1 North America Carasil Treatment Market Size by Application (2016-2021)
6.3.2 North America Carasil Treatment Market Size by Application (2022-2027)
6.3.3 North America Carasil Treatment Market Size by Application (2016-2027)
6.4 North America Carasil Treatment Market Size by Country
6.4.1 North America Carasil Treatment Market Size by Country (2016-2021)
6.4.2 North America Carasil Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Carasil Treatment Market Size (2016-2027)
7.2 Europe Carasil Treatment Market Size by Type
7.2.1 Europe Carasil Treatment Market Size by Type (2016-2021)
7.2.2 Europe Carasil Treatment Market Size by Type (2022-2027)
7.2.3 Europe Carasil Treatment Market Size by Type (2016-2027)
7.3 Europe Carasil Treatment Market Size by Application
7.3.1 Europe Carasil Treatment Market Size by Application (2016-2021)
7.3.2 Europe Carasil Treatment Market Size by Application (2022-2027)
7.3.3 Europe Carasil Treatment Market Size by Application (2016-2027)
7.4 Europe Carasil Treatment Market Size by Country
7.4.1 Europe Carasil Treatment Market Size by Country (2016-2021)
7.4.2 Europe Carasil Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Carasil Treatment Market Size (2016-2027)
8.2 Asia-Pacific Carasil Treatment Market Size by Type
8.2.1 Asia-Pacific Carasil Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Carasil Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Carasil Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Carasil Treatment Market Size by Application
8.3.1 Asia-Pacific Carasil Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Carasil Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Carasil Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Carasil Treatment Market Size by Region
8.4.1 Asia-Pacific Carasil Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Carasil Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Carasil Treatment Market Size (2016-2027)
9.2 Latin America Carasil Treatment Market Size by Type
9.2.1 Latin America Carasil Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Carasil Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Carasil Treatment Market Size by Type (2016-2027)
9.3 Latin America Carasil Treatment Market Size by Application
9.3.1 Latin America Carasil Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Carasil Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Carasil Treatment Market Size by Application (2016-2027)
9.4 Latin America Carasil Treatment Market Size by Country
9.4.1 Latin America Carasil Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Carasil Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Carasil Treatment Market Size (2016-2027)
10.2 Middle East & Africa Carasil Treatment Market Size by Type
10.2.1 Middle East & Africa Carasil Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Carasil Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Carasil Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Carasil Treatment Market Size by Application
10.3.1 Middle East & Africa Carasil Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Carasil Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Carasil Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Carasil Treatment Market Size by Country
10.4.1 Middle East & Africa Carasil Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Carasil Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Carasil Treatment Introduction
11.1.4 GlaxoSmithKline Revenue in Carasil Treatment Business (2016-2021)
11.1.5 GlaxoSmithKline Recent Development
11.2 Raptor Pharmaceutical
11.2.1 Raptor Pharmaceutical Company Details
11.2.2 Raptor Pharmaceutical Business Overview
11.2.3 Raptor Pharmaceutical Carasil Treatment Introduction
11.2.4 Raptor Pharmaceutical Revenue in Carasil Treatment Business (2016-2021)
11.2.5 Raptor Pharmaceutical Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Carasil Treatment Introduction
11.3.4 Pfizer Revenue in Carasil Treatment Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Vertex Pharmaceuticals Incorporated
11.4.1 Vertex Pharmaceuticals Incorporated Company Details
11.4.2 Vertex Pharmaceuticals Incorporated Business Overview
11.4.3 Vertex Pharmaceuticals Incorporated Carasil Treatment Introduction
11.4.4 Vertex Pharmaceuticals Incorporated Revenue in Carasil Treatment Business (2016-2021)
11.4.5 Vertex Pharmaceuticals Incorporated Recent Development
11.5 Ceregene Inc.
11.5.1 Ceregene Inc. Company Details
11.5.2 Ceregene Inc. Business Overview
11.5.3 Ceregene Inc. Carasil Treatment Introduction
11.5.4 Ceregene Inc. Revenue in Carasil Treatment Business (2016-2021)
11.5.5 Ceregene Inc. Recent Development
11.6 AmpliPhi Biosciences Corporation
11.6.1 AmpliPhi Biosciences Corporation Company Details
11.6.2 AmpliPhi Biosciences Corporation Business Overview
11.6.3 AmpliPhi Biosciences Corporation Carasil Treatment Introduction
11.6.4 AmpliPhi Biosciences Corporation Revenue in Carasil Treatment Business (2016-2021)
11.6.5 AmpliPhi Biosciences Corporation Recent Development
11.7 H. Lundbeck A/S
11.7.1 H. Lundbeck A/S Company Details
11.7.2 H. Lundbeck A/S Business Overview
11.7.3 H. Lundbeck A/S Carasil Treatment Introduction
11.7.4 H. Lundbeck A/S Revenue in Carasil Treatment Business (2016-2021)
11.7.5 H. Lundbeck A/S Recent Development
11.8 Omeros Ipsen
11.8.1 Omeros Ipsen Company Details
11.8.2 Omeros Ipsen Business Overview
11.8.3 Omeros Ipsen Carasil Treatment Introduction
11.8.4 Omeros Ipsen Revenue in Carasil Treatment Business (2016-2021)
11.8.5 Omeros Ipsen Recent Development
11.9 Novartis AG
11.9.1 Novartis AG Company Details
11.9.2 Novartis AG Business Overview
11.9.3 Novartis AG Carasil Treatment Introduction
11.9.4 Novartis AG Revenue in Carasil Treatment Business (2016-2021)
11.9.5 Novartis AG Recent Development
11.10 Aurobindo Pharma
11.10.1 Aurobindo Pharma Company Details
11.10.2 Aurobindo Pharma Business Overview
11.10.3 Aurobindo Pharma Carasil Treatment Introduction
11.10.4 Aurobindo Pharma Revenue in Carasil Treatment Business (2016-2021)
11.10.5 Aurobindo Pharma Recent Development
11.11 Prana Biotechnology
11.11.1 Prana Biotechnology Company Details
11.11.2 Prana Biotechnology Business Overview
11.11.3 Prana Biotechnology Carasil Treatment Introduction
11.11.4 Prana Biotechnology Revenue in Carasil Treatment Business (2016-2021)
11.11.5 Prana Biotechnology Recent Development
11.12 Alnylam Pharmaceuticals Inc.
11.12.1 Alnylam Pharmaceuticals Inc. Company Details
11.12.2 Alnylam Pharmaceuticals Inc. Business Overview
11.12.3 Alnylam Pharmaceuticals Inc. Carasil Treatment Introduction
11.12.4 Alnylam Pharmaceuticals Inc. Revenue in Carasil Treatment Business (2016-2021)
11.12.5 Alnylam Pharmaceuticals Inc. Recent Development
11.13 SOM Biotech
11.13.1 SOM Biotech Company Details
11.13.2 SOM Biotech Business Overview
11.13.3 SOM Biotech Carasil Treatment Introduction
11.13.4 SOM Biotech Revenue in Carasil Treatment Business (2016-2021)
11.13.5 SOM Biotech Recent Development
11.14 Teva Pharmaceutical Industries Ltd.
11.14.1 Teva Pharmaceutical Industries Ltd. Company Details
11.14.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.14.3 Teva Pharmaceutical Industries Ltd. Carasil Treatment Introduction
11.14.4 Teva Pharmaceutical Industries Ltd. Revenue in Carasil Treatment Business (2016-2021)
11.14.5 Teva Pharmaceutical Industries Ltd. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Carasil Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Vesicular Monoamine Transporter 2 Inhibitors
Table 3. Key Players of Selective Serotonin Reuptake Inhibitor (SSRI)
Table 4. Key Players of Cholinergic/ Cholinesterase (Che) Inhibitors
Table 5. Key Players of Atypical Antipsychotic Drugs
Table 6. Key Players of Combined Drug (Donepezil & Memantine)
Table 7. Key Players of MAO Inhibitors
Table 8. Key Players of Glutamate Inhibitors
Table 9. Global Carasil Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Carasil Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Carasil Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Carasil Treatment Market Share by Regions (2016-2021)
Table 13. Global Carasil Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Carasil Treatment Market Share by Regions (2022-2027)
Table 15. Carasil Treatment Market Trends
Table 16. Carasil Treatment Market Drivers
Table 17. Carasil Treatment Market Challenges
Table 18. Carasil Treatment Market Restraints
Table 19. Global Carasil Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Carasil Treatment Market Share by Players (2016-2021)
Table 21. Global Top Carasil Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Carasil Treatment as of 2020)
Table 22. Ranking of Global Top Carasil Treatment Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Carasil Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Carasil Treatment Product Solution and Service
Table 26. Date of Enter into Carasil Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Carasil Treatment Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Carasil Treatment Revenue Market Share by Type (2016-2021)
Table 30. Global Carasil Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Carasil Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Carasil Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Carasil Treatment Revenue Market Share by Application (2016-2021)
Table 34. Global Carasil Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Carasil Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Carasil Treatment Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Carasil Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Carasil Treatment Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Carasil Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Carasil Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Carasil Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Carasil Treatment Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Carasil Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Carasil Treatment Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Carasil Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Carasil Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Carasil Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Carasil Treatment Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Carasil Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Carasil Treatment Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Carasil Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Carasil Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Carasil Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Carasil Treatment Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Carasil Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Carasil Treatment Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Carasil Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Carasil Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Carasil Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Carasil Treatment Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Carasil Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Carasil Treatment Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Carasil Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Carasil Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Carasil Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 66. GlaxoSmithKline Company Details
Table 67. GlaxoSmithKline Business Overview
Table 68. GlaxoSmithKline Carasil Treatment Product
Table 69. GlaxoSmithKline Revenue in Carasil Treatment Business (2016-2021) & (US$ Million)
Table 70. GlaxoSmithKline Recent Development
Table 71. Raptor Pharmaceutical Company Details
Table 72. Raptor Pharmaceutical Business Overview
Table 73. Raptor Pharmaceutical Carasil Treatment Product
Table 74. Raptor Pharmaceutical Revenue in Carasil Treatment Business (2016-2021) & (US$ Million)
Table 75. Raptor Pharmaceutical Recent Development
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer Carasil Treatment Product
Table 79. Pfizer Revenue in Carasil Treatment Business (2016-2021) & (US$ Million)
Table 80. Pfizer Recent Development
Table 81. Vertex Pharmaceuticals Incorporated Company Details
Table 82. Vertex Pharmaceuticals Incorporated Business Overview
Table 83. Vertex Pharmaceuticals Incorporated Carasil Treatment Product
Table 84. Vertex Pharmaceuticals Incorporated Revenue in Carasil Treatment Business (2016-2021) & (US$ Million)
Table 85. Vertex Pharmaceuticals Incorporated Recent Development
Table 86. Ceregene Inc. Company Details
Table 87. Ceregene Inc. Business Overview
Table 88. Ceregene Inc. Carasil Treatment Product
Table 89. Ceregene Inc. Revenue in Carasil Treatment Business (2016-2021) & (US$ Million)
Table 90. Ceregene Inc. Recent Development
Table 91. AmpliPhi Biosciences Corporation Company Details
Table 92. AmpliPhi Biosciences Corporation Business Overview
Table 93. AmpliPhi Biosciences Corporation Carasil Treatment Product
Table 94. AmpliPhi Biosciences Corporation Revenue in Carasil Treatment Business (2016-2021) & (US$ Million)
Table 95. AmpliPhi Biosciences Corporation Recent Development
Table 96. H. Lundbeck A/S Company Details
Table 97. H. Lundbeck A/S Business Overview
Table 98. H. Lundbeck A/S Carasil Treatment Product
Table 99. H. Lundbeck A/S Revenue in Carasil Treatment Business (2016-2021) & (US$ Million)
Table 100. H. Lundbeck A/S Recent Development
Table 101. Omeros Ipsen Company Details
Table 102. Omeros Ipsen Business Overview
Table 103. Omeros Ipsen Revenue in Carasil Treatment Business (2016-2021) & (US$ Million)
Table 104. Omeros Ipsen Recent Development
Table 105. Novartis AG Company Details
Table 106. Novartis AG Business Overview
Table 107. Novartis AG Carasil Treatment Product
Table 108. Novartis AG Revenue in Carasil Treatment Business (2016-2021) & (US$ Million)
Table 109. Novartis AG Recent Development
Table 110. Aurobindo Pharma Company Details
Table 111. Aurobindo Pharma Business Overview
Table 112. Aurobindo Pharma Carasil Treatment Product
Table 113. Aurobindo Pharma Revenue in Carasil Treatment Business (2016-2021) & (US$ Million)
Table 114. Aurobindo Pharma Recent Development
Table 115. Prana Biotechnology Company Details
Table 116. Prana Biotechnology Business Overview
Table 117. Prana Biotechnology Carasil Treatment Product
Table 118. Prana Biotechnology Revenue in Carasil Treatment Business (2016-2021) & (US$ Million)
Table 119. Prana Biotechnology Recent Development
Table 120. Alnylam Pharmaceuticals Inc. Company Details
Table 121. Alnylam Pharmaceuticals Inc. Business Overview
Table 122. Alnylam Pharmaceuticals Inc. Carasil Treatment Product
Table 123. Alnylam Pharmaceuticals Inc. Revenue in Carasil Treatment Business (2016-2021) & (US$ Million)
Table 124. Alnylam Pharmaceuticals Inc. Recent Development
Table 125. SOM Biotech Company Details
Table 126. SOM Biotech Business Overview
Table 127. SOM Biotech Carasil Treatment Product
Table 128. SOM Biotech Revenue in Carasil Treatment Business (2016-2021) & (US$ Million)
Table 129. SOM Biotech Recent Development
Table 130. Teva Pharmaceutical Industries Ltd. Company Details
Table 131. Teva Pharmaceutical Industries Ltd. Business Overview
Table 132. Teva Pharmaceutical Industries Ltd. Carasil Treatment Product
Table 133. Teva Pharmaceutical Industries Ltd. Revenue in Carasil Treatment Business (2016-2021) & (US$ Million)
Table 134. Teva Pharmaceutical Industries Ltd. Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Carasil Treatment Market Share by Type: 2020 VS 2027
Figure 2. Vesicular Monoamine Transporter 2 Inhibitors Features
Figure 3. Selective Serotonin Reuptake Inhibitor (SSRI) Features
Figure 4. Cholinergic/ Cholinesterase (Che) Inhibitors Features
Figure 5. Atypical Antipsychotic Drugs Features
Figure 6. Combined Drug (Donepezil & Memantine) Features
Figure 7. MAO Inhibitors Features
Figure 8. Glutamate Inhibitors Features
Figure 9. Global Carasil Treatment Market Share by Application: 2020 VS 2027
Figure 10. Hospital Case Studies
Figure 11. Clinics Case Studies
Figure 12. Drug Store Case Studies
Figure 13. Online Pharmacies Case Studies
Figure 14. Carasil Treatment Report Years Considered
Figure 15. Global Carasil Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Carasil Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Carasil Treatment Market Share by Regions: 2020 VS 2027
Figure 18. Global Carasil Treatment Market Share by Regions (2022-2027)
Figure 19. Global Carasil Treatment Market Share by Players in 2020
Figure 20. Global Top Carasil Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Carasil Treatment as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Carasil Treatment Revenue in 2020
Figure 22. Global Carasil Treatment Revenue Market Share by Type (2016-2021)
Figure 23. Global Carasil Treatment Revenue Market Share by Type (2022-2027)
Figure 24. North America Carasil Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Carasil Treatment Market Share by Type (2016-2027)
Figure 26. North America Carasil Treatment Market Share by Application (2016-2027)
Figure 27. North America Carasil Treatment Market Share by Country (2016-2027)
Figure 28. United States Carasil Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Carasil Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Carasil Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Carasil Treatment Market Share by Type (2016-2027)
Figure 32. Europe Carasil Treatment Market Share by Application (2016-2027)
Figure 33. Europe Carasil Treatment Market Share by Country (2016-2027)
Figure 34. Germany Carasil Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Carasil Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Carasil Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Carasil Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Carasil Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Carasil Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Carasil Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Carasil Treatment Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Carasil Treatment Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Carasil Treatment Market Share by Region (2016-2027)
Figure 44. China Carasil Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Carasil Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Carasil Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Carasil Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Carasil Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Carasil Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Carasil Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Carasil Treatment Market Share by Type (2016-2027)
Figure 52. Latin America Carasil Treatment Market Share by Application (2016-2027)
Figure 53. Latin America Carasil Treatment Market Share by Country (2016-2027)
Figure 54. Mexico Carasil Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Carasil Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Carasil Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Carasil Treatment Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Carasil Treatment Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Carasil Treatment Market Share by Country (2016-2027)
Figure 60. Turkey Carasil Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Carasil Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Carasil Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. GlaxoSmithKline Revenue Growth Rate in Carasil Treatment Business (2016-2021)
Figure 64. Raptor Pharmaceutical Revenue Growth Rate in Carasil Treatment Business (2016-2021)
Figure 65. Pfizer Revenue Growth Rate in Carasil Treatment Business (2016-2021)
Figure 66. Vertex Pharmaceuticals Incorporated Revenue Growth Rate in Carasil Treatment Business (2016-2021)
Figure 67. Ceregene Inc. Revenue Growth Rate in Carasil Treatment Business (2016-2021)
Figure 68. AmpliPhi Biosciences Corporation Revenue Growth Rate in Carasil Treatment Business (2016-2021)
Figure 69. H. Lundbeck A/S Revenue Growth Rate in Carasil Treatment Business (2016-2021)
Figure 70. Omeros Ipsen Revenue Growth Rate in Carasil Treatment Business (2016-2021)
Figure 71. Novartis AG Revenue Growth Rate in Carasil Treatment Business (2016-2021)
Figure 72. Aurobindo Pharma Revenue Growth Rate in Carasil Treatment Business (2016-2021)
Figure 73. Prana Biotechnology Revenue Growth Rate in Carasil Treatment Business (2016-2021)
Figure 74. Alnylam Pharmaceuticals Inc. Revenue Growth Rate in Carasil Treatment Business (2016-2021)
Figure 75. SOM Biotech Revenue Growth Rate in Carasil Treatment Business (2016-2021)
Figure 76. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Carasil Treatment Business (2016-2021)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
世界の選択的セロトニン再取り込み阻害薬（SSRI）市場規模・現状・予測（2021年-2027年） Selective serotonin reuptake inhibitors (SSRIs) are the most commonly prescribed antidepressants. They can ease symptoms of moderate to severe depression, are relatively safe and typically cause fewer side effects than other types of antidepressants do. With an increase in mental illnesses, there is…- 選択的セロトニン再取り込み阻害薬（SSRI）のグローバル市場：規模・現状・予測2019-2025 Selective serotonin reuptake inhibitors (SSRIs) are the most commonly prescribed antidepressants. They can ease symptoms of moderate to severe depression, are relatively safe and typically cause fewer side effects than other types of antidepressants do.With an increase in mental illnesses, there is …
- 選択的セロトニン再取り込み阻害薬（SSRI）のグローバル市場：規模・現状・予測2019-2025 Selective serotonin reuptake inhibitors (SSRIs) are the most commonly prescribed antidepressants. They can ease symptoms of moderate to severe depression, are relatively safe and typically cause fewer side effects than other types of antidepressants do.With an increase in mental illnesses, there is …
- 世界のノイラミニダーゼ阻害薬市場規模・現状・予測（2021年-2027年） Neuraminidase Inhibitors (NAIs) are the type of drugs that are used to block the neuraminidase enzyme. Market Analysis and Insights: Global Neuraminidase Inhibitors Drug Market The global Neuraminidase Inhibitors Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2…
- 世界のBCL-2（B細胞リンパ腫2）阻害剤市場規模・現状・予測（2021年-2027年） Bcl-2 (B-cell lymphoma 2), encoded in humans by the BCL2 gene, is the founding member of the Bcl-2 family of regulator proteins that regulate cell death (apoptosis), by either inhibiting (anti-apoptotic) or inducing (pro-apoptotic) apoptosis. Market Analysis and Insights: Global BCL-2 (B-cell lympho…